This nationwide prescription-based study was undertaken to evaluate antimicrobial prescribing for infants, and to identify prescribing errors in infants in 20 primary care health centres of Bahrain. Data was collected on a daily basis by pharmacists in May 2004. Antimicrobials ranked the 5th most common drugs prescribed in infants; -lactams, notably amoxycillin and cephalexin, comprised 81.6% of overall prescribed antimicrobials. Antimicrobials were prescribed to approximately one out of four infants (23.8%), prescribed more often to infants aged 9-12 months of age. Approximately one-fifth (22%) of infants received antimicrobials at subtherapeutic daily doses. The prescribing errors were related to dosage (39.2%), strength/doses (26.4%), frequency of dosing (19.2%), and duration of therapy (4.5%). Antimicrobial dosage prescribed in relation to infants' age revealed a positive correlation for amoxycillin (r ¼ 0.264; p < 0.0001), cephalexin (r ¼ 0.223; p ¼ 0.029), erythromycin (r ¼ 0.127; p ¼ 0.284), and a negative correlation for metronidazole (r ¼ -0.183; p ¼ 0.415). Overt use of antimicrobials in infants, and prescription-writing errors (in dosages and frequency of dosing) were common in primary care. Dosage adjustment in relation to developmental stages of infants has received inadequate attention. Effective strategies to improve prescription writing skills are urgently required.
Introduction
It is well known that the stages of development among pediatric age group are associated with marked variability in the pharmacokinetics and pharmacodynamics of antimicrobial agents. In addition to age-related factors, pharmacokinetics and pharmacodynamics of antibacterial agents are altered by hepatic immaturity, renal immaturity, and volume of distribution, tissue distribution and gastrointestinal absorption of drugs [1, 2] . Considering these factors allows a more rational use of antimicrobial agents, especially in pediatrics.
Although the prescribing of antimicrobials in children has been addressed [3] [4] [5] [6] , very few studies have been carried out in infants. This nationwide study has evaluated the prescribing profile and prescribing errors of antimicrobials in infants, in primary care.
Material and Methods

Setting
In Bahrain, 11.4% of the population are children 4 years of age. A network of 20 primary care health centres provides free health care, including dispensing essential drugs for citizens and residents. Prescriptions issued to infants at health centres between 9th and 23rd of May 2004 were analyzed for prescribing pattern and prescribing errors.
Data source and variability
The minimal and maximal daily dose ranges of antimicrobials for infants used were calculated using adult percentage method [7, 8] . The minimal dose represents 14.5% of adult dose for a one-month-old infant whereas the maximal dose represents 25% of adult dose for a 12-month-old infant [7, 8] . A therapeutic dose was defined as the total dose of antimicrobial that ranges between the minimal and maximal doses. A subtherapeutic dose was defined as the total dose of antimicrobial that was less than the defined minimal dose, and supratherapeutic dose as the total dose of antimicrobial that exceeds the maximal daily dose. On the basis of adult dosage regimens for non-severe infection [7] [8] [9] estimated minimal and maximal dose (mg/d) ranges were: amoxycillin 218-375, cephalexin 290-500, erythromycin 290-500, metronidazole 174-300, cloxacillin 290-500, and cotrimoxazole 140-240.
Absence, and/or incomplete component of prescription is considered as major errors of omission, whereas incorrectly written component(s), as an error of commission [10] .
Statistical analysis
Data were analyzed using Statistical Package for the Social Science (SPSS/PCþ, version 9.0). Two-tailed Spearman coefficient was used to determine correlation; p < 0.05 was considered statistically significant.
Results
The rate of drugs prescribed from various therapeutic classes were ranked as follows: central nervous system including paracetamol (61.8%), respiratory (53.5%), ear, nose and throat (44.9%), skin (25.5%), antimicrobials (23.8%), nutrition & blood (18.1%), eye (12.6%) and gastrointestinal tract (11.6%) (data not shown).
Of 2282 dispensed prescriptions, 543 (23.8%) included an antimicrobial agent. The mean age of study population (AESD) was 6.5 AE 3.1 months. Systemic antimicrobials prescribed according to age (months) were as follows: <1 (0.0%), 1 to <3 (3.1%), 3 to <6 (18.6%), 6 to <9 (36.5%), and 9 to <12 (41.8%). Antimicrobials were prescribed more often to infants aged 9-12 months.
The most frequently prescribed antimicrobial was amoxycillin (63.9%), followed by cephalexin (17.7%), erythromycin (13.4%) and metronidazole (4.1%), cotrimoxazole (0.6%) and cloxacillin (0.4%).
The proportion of antimicrobials prescribed at subtherapeutic, therapeutic and supratherapeutic doses were 119 (22.0%), 394 (72.8%) and 28 (5.2%), respectively (Table 1) .
With respect to major errors of omission, duration of therapy and dosage form were frequently omitted components of the prescription; these comprised 4.5% (n ¼ 24) and 39.2% (n ¼ 211), respectively. Dosing frequency (n ¼ 103, 19.2%) and dosage (n ¼ 142, 26.4%) of antimicrobials were the foremost errors of commission (Table 2) .
Correlation between the daily dose of antimicrobials and the age of infants are presented in Table 3 .
Discussion
Although dosage schedules for children have been determined by clinical trial or experience, often it is scaled down from adult dosage using bodyweight, body-surface area, age or by a combination of these parameters [7, 11] . Each of these methods has advantages and disadvantages [7] . We have used adult dose percentage method because infants' weight and length were not available. Although an approximation, the percentage methods may be safely used to calculate pediatric dose of drugs prescribed in primary care with a wide margin between the therapeutic and toxic doses [7] . Almost all antimicrobial oral formulations for pediatric use available at the health centres in Bahrain (amoxycillin, cephalexin, cloxacillin, cotrimoxazole, erythromycin, griseofulvin, metronidazole, and mebendazole) have a wide therapeutic index.
Antimicrobials ranked the 5th most commonly prescribed classes of drugs to infants (approximately one out of four infants) in primary care in our study. There is a possible association between the antibiotic use in children during their first year of life In 2 out of 347 prescriptions amoxycillin dosage was not specified; Numbers within parenthesis represent the dispensed prescriptions.
(infancy) and the increased risk for developing subsequent bronchial asthma and allergy in children with genetic predisposition [12] , although this view has been challenged [13] . Nonetheless, the above issue should be considered while prescribing antimicrobials.
Administration of antimicrobials at subtherapeutic dosages contribute to treatment failure and selective pressure for resistance [14] [15] [16] . Approximately onefifth (22%) of treated infants received antimicrobials at subtherapeutic dosage (Table 1) . It is likely that reasons for subtherapeutic dosage included prescribing errors, particularly inappropriate dosing frequency. It is also plausible that prescribing -lactam antibiotics and erythromycin at less than recommended dosing frequency (Table 2 ) may produce suboptimal clinical response by decreasing the duration of antibacterial concentration at or above the MIC, a key determinant of time-dependant antibacterial efficacy [17] .
Because of rapidly changing size, bodyweight and physiological functions in children who are growing and recovering from illness, constant adjustment of dosage regimen is necessary [18] . Significant positive correlation for amoxycillin and cephalexin, nonsignificant correlation for erythromycin, and nonsignificant negative correlation for metronidazole were found between the mean daily dosage of antimicrobials and age of infants (Table 3 ). This observation suggests that the dosage in relation to developmental stages of infants has received inadequate attention.
Although cotrimoxazole has been rarely prescribed in our study sample, caution should be exercised to avoid haemolysis secondary to the high prevalence of glucose-6-phosphate dehydrogenase deficiency in Bahrain [19] .
Conclusion
Overt use of antimicrobials, and prescription-writing errors (in dosages and frequency of dosing), are common in infants treated in primary care. Dosage adjustment in relation to developmental stages of infants has received inadequate attention. Effective strategies to improve prescription writing skills are urgently required. There is a need to introduce programmes to enhance rational antimicrobial therapy in infants. Prescription audit is helpful to identify the priority areas for interventions. Establishing both national drug policy and pharmacovigilance programme are to be considered.
